<DOC>
	<DOCNO>NCT01315756</DOCNO>
	<brief_summary>It hypothesize use mobile phone-based self-help system FTA , patient active player , improve diabetes self-management reflect improved glycemic control lipid , self-care behaviour lifestyle change improve dietary habit increase physical activity , compare usual care . Following ; also hypothesize also lead reduction overall risk diabetes complication ( express reduction e.g. , 5 year absolute risk coronary artery disease calculate use Swedish National Diabetes Register 's risk calculator ) prevalence metabolic syndrome ( e.g. , define International Diabetes Federation ) . It also hypothesize health counselling base TTM CBT diabetes nurse , individualized feedback via sm diabetes nurse , may important function supplement self-help system ( FTA ) . In addition , hypothesize patient ' health status diabetes-related quality life ( HRQL ) improve . The result study may show commonly used tool like mobile phone , also mobile phone together health counselling , fit patient ' daily life , effective cost-effective standard care .</brief_summary>
	<brief_title>Self-management Type 2 Diabetes Patients Using Few Touch Application</brief_title>
	<detailed_description>The purpose study examine effectiveness mobile phone-based lifestyle tool , health counsel use tailored SMS individual phone-calls patient , self-management T2DM . Maintaining daily symptom diary ( describe ) easy way self-monitoring appear offer valid reliable way assess behaviour . In addition , patient able view registration Smartphone , i.e . programmable mobile phone touch sensitive screen . The self-help system , call `` Few Touch application '' , recently test 12 people T2DM NST , University Hospital North Norway ( UNN ) , form basis patient ' mobile interaction system .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age &gt; 18 ; diagnose T2DM &gt; 3 month prior study inclusion ; case patient receive one glucose lower drug ( e.g. , metformin , sulphonylurea , glinide , αglucosidase inhibitor , DPPIV inhibitor , GLP1 analogue , glitazone , insulin ) treatment stabilize ( i.e. , change dosage last three month prior inclusion except insulin treat patient allow ±15 % dose adjustment ; HbA1c &gt; 7 % ; capability understand fill Norwegian questionnaire ; able use system provide ; cognitive able participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>